Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2026-05-20 Declaration of Voting R…
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Results of Meeting 2 pages 337.1KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement titled “Results of Annual General Meeting” summarizing proxy votes and poll results under Listing Rule 3.13.2 and Section 251AA(2) of the Corporations Act. It provides the voting outcomes for each resolution, which matches the definition of Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-20 English
Application for quotation of securities - HMD 7 pages 19.5KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Appendix 2A “Application for quotation of securities,” detailing the issuance of 2.5 million new ordinary shares following option conversions and requesting their quotation on ASX. This is a direct announcement of a share issue/capital change rather than a report publication or regulatory certification. Therefore it falls under the “Share Issue/Capital Change” category.
2026-05-10 English
Quarterly Activities & Cashflow Report 9 pages 543.7KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 30 April 2026 titled '1Q FY26: Quarterly Activities & Cashflow Report'. It provides a detailed review of the company's quarterly operational highlights, commercial partnerships, advisory board appointments, and financial update including cash flow details for the quarter ended 31 March 2026. The presence of an Appendix 4C cash flow statement, which is a standard quarterly report format for Australian listed companies, confirms this is a quarterly financial report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year (the first quarter of FY26). It is not merely an announcement of a report or a certification, but a comprehensive interim financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2026
2026-04-29 English
Notification regarding unquoted securities - HMD 6 pages 19.3KB
Share Issue/Capital Change Classification · 98% confidence The document is an ASX ‘Appendix 3G’ notification detailing the issue of unquoted equity securities (performance rights) under an employee incentive scheme. This is a direct announcement of new share/equity issuance. It does not fit executive management changes, dividends, or legal proceedings. It corresponds to a Share Issue/Capital Change filing.
2026-04-26 English
Notification regarding unquoted securities - HMD 7 pages 21.8KB
Share Issue/Capital Change Classification · 87% confidence The document is an ASX Appendix 3G notice detailing the issue of new unquoted equity securities (employee options) by Heramed Limited. This is an announcement of a share issuance/capital change event under ASX Listing Rules. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-04-26 English
Change of Director's Interest Notice TC DH SR 9 pages 361.3KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” showing detailed movements in securities held by multiple directors under ASX Listing Rule 3.19A. It records numbers of securities acquired/disposed, nature of interests, dates, and related trust details. This is a direct insider transaction report, matching the definition of Director’s Dealing. There is no indication that it is a publication announcement or any other category.
2026-04-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.